脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法)

ELISA Kit for Phospholipase A2 Group VII (LpPLA2)

PLA2G7; PAF-AH; PAFAH; Lp-PLA2; LDL-PLA2; Platelet Activating Factor Acetylhydrolase,Plasma; Phospholipase A2,Group VII; LDL-associated phospholipase A2; Phospholipase A2, Lipoprotein Associated

  • 脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法) 产品包装(模拟)
  • 脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法) 产品包装(模拟)
  • 脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法) 实验结果图
  • SEA867Hu.jpg 标准曲线图
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测脂蛋白关联磷脂酶A2(LpPLA2)，经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制，不可能完成对所有相关或相似物质交叉反应检测，因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的脂蛋白关联磷脂酶A2(LpPLA2)（加标样品），重复测定并计算其均值，回收率为测定值与理论值的比率。

样本 回收率范围(%) 平均回收率(%)
serum(n=5) 96-105 101
EDTA plasma(n=5) 78-104 91
heparin plasma(n=5) 85-96 91

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差：取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次，分别计算不同浓度样本的平均值及SD值。
批间差：选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定，每个样本使用同一试剂盒重复测定8次，分别计算不同浓度样本的平均值及SD值。
批内差： CV<10%
批间差： CV<12%

线性

在定值血清及血浆样本内加入适量的脂蛋白关联磷脂酶A2(LpPLA2)，并倍比稀释成1:2，1:4，1:8，1:16的待测样本，线性范围即为稀释后样本中脂蛋白关联磷脂酶A2(LpPLA2)含量的测定值与理论值的比率。

样本 1:2 1:4 1:8 1:16
serum(n=5) 82-91% 89-99% 83-98% 96-104%
EDTA plasma(n=5) 98-105% 89-97% 78-101% 78-94%
heparin plasma(n=5) 78-95% 83-97% 78-102% 94-101%

稳定性

经测定，试剂盒在有效期内按推荐温度保存，其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响，实验室的环境条件需尽量保持一致，尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本的准备；
2. 加样（标准品及样本）100µL，37°C孵育1小时；
3. 吸弃，加检测溶液A100µL，37°C孵育1小时；
4. 洗板3次；
5. 加检测溶液B100µL，37°C孵育30分钟；
6. 洗板5次；
7. 加TMB底物90µL，37°C孵育10-20分钟；
8. 加终止液50µL，立即450nm读数。

实验原理

将脂蛋白关联磷脂酶A2(LpPLA2)抗体包被于96孔微孔板中，制成固相载体，向微孔中分别加入标准品或标本，其中的脂蛋白关联磷脂酶A2(LpPLA2)与连接于固相载体上的抗体结合，然后加入生物素化的脂蛋白关联磷脂酶A2(LpPLA2)抗体，将未结合的生物素化抗体洗净后，加入HRP标记的亲和素，再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色，并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的脂蛋白关联磷脂酶A2(LpPLA2)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值)，计算样品浓度。

相关产品

编号 适用物种：Homo sapiens (Human，人) 应用(仅供研究使用，不用于临床诊断！)
URPA867Hu02 脂蛋白关联磷脂酶A2(LpPLA2)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
URPA867Hu03 脂蛋白关联磷脂酶A2(LpPLA2)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
URPA867Hu04 脂蛋白关联磷脂酶A2(LpPLA2)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UAPA867Hu01 脂蛋白关联磷脂酶A2(LpPLA2)活性蛋白 Cell culture; Activity Assays.
URPA867Hu01 脂蛋白关联磷脂酶A2(LpPLA2)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAA867Hu01 脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体 WB
ULAA867Hu81 脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
ULAA867Hu71 脂蛋白关联磷脂酶A2(LpPLA2)多克隆抗体(生物素标记) WB; IHC; ICC.
UMAA867Hu21 脂蛋白关联磷脂酶A2(LpPLA2)单克隆抗体 Testing in progress
UMAA867Hu22 脂蛋白关联磷脂酶A2(LpPLA2)单克隆抗体 WB
UFAA867Hu02 抗脂蛋白关联磷脂酶A2(LpPLA2)单克隆抗体 Flow cytometry.
USEA867Hu 脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
USCA867Hu 脂蛋白关联磷脂酶A2(LpPLA2)检测试剂盒(化学发光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.
ULMA867Hu 脂蛋白关联磷脂酶A2(LpPLA2)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.
UCMA867Hu 脂蛋白关联磷脂酶A2(LpPLA2)等多因子检测试剂盒(流式荧光法) FLIA Kit for Antigen Detection.

参考文献

杂志 参考文献
Science & Sports The effects of different intensity walking programs on serum blood lipids, high-sensitive C-reactive protein, and lipoprotein-associated phospholipase A2 in premenopausal women [ScienceDirect: S0765159710000262]
Metabolic Syndrome and Related Disorders Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease [Wiley: source]
34 Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study [PubMed: 22240497]
PLoS ONE Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo [PubMed: PMC3759413]
China Pharmacy Influence of Tongfengtai Granules on Inflammatory Factor in Acute Gouty Arthritis Model Rats [Source]
Atherosclerosis Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients. [Pubmed: 23958269]
Journal of Diabetes Research Lipoprotein-Associated Phospholipase A2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus [Hindawi: 278063]
Health The Role of Asymmetric Dimethylarginine and Lipoprotein Associated Phospholipase A2 in Children and Adolescents with Dyslipidemia [Scirp:Source]
Biology Bulletin In vitro lipid-lowering and fibrinolytic effects of regulatory leucine-containing glyprolines in human blood [Springer:Source]
Gynecol Endocrinol. Lipoprotein-associated phospholipase A2 and AGEs are associated with cardiovascular risk factors in women with history of gestational diabetes mellitus. [Pubmed:24397392]
Journal of Diabetes Research Lipoprotein-Associated Phospholipase A 2 Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus [Pubmed:24818163]
Metabolism. Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes [Pubmed:25034387]
J Am Heart Assoc Effect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients [PubMed: 26374297]
Czecho-Slovak Dermatology / Cesko-Slovenska Dermatologie V [Ebscohost]
Endocrinol Metab (Seoul). Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA2 in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome [pmc:PMC4803547]
Clin Pharmacol Ther.  Effect of dipyridamole on myocardial reperfusion injury: A double‐blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery [Pubmed:25773594]
Lipids in Health and Disease Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A 2 and secretory phospholipase A 2 in patients with newly … [articles:10.1186]
Acta Endocrinologica SERUM LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN MALES WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA. [jrnl:1841098]
Biomarker for diagnosis of moyamoya disease [:]
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions [Pubmed: 32859455]
chinese neurosurgical journal Can admission lipoprotein-associated phospholipase A2 predict the symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage? []
留言咨询